Imagenebio, Inc. (IMA) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Imagenebio, Inc. on February 17, 2026, covering events occurring on February 12, 2026. The Company is incorporated in Delaware and trades on The Nasdaq Capital Market under the symbol "IMA".
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
On February 12, 2026, Steven Hui Wang resigned as a member of the Board of Directors, effective immediately. The Company stated that Mr. Wang's resignation was not the result of any disagreement with the Company regarding operations, policies, practices, or strategy.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the disclosure of the director's departure.
Key Facts for Investor Verification
- Steven Hui Wang is no longer a member of the Board of Directors as of February 12, 2026.
- The resignation was voluntary and not linked to any disagreement with Company management.
- Dr. Kristin Yarema, Chief Executive Officer, signed the report on February 17, 2026.
- No financial data or operational updates are included in this specific filing.